Nishida Yoshihiro, Tsukushi Satoshi, Urakawa Hiroshi, Hamada Shunsuke, Kozawa Eiji, Ikuta Kunihiro, Ishiguro Naoki
Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.
Oncol Lett. 2016 Aug;12(2):1564-1568. doi: 10.3892/ol.2016.4792. Epub 2016 Jun 28.
Desmoid tumors of the extra-abdominal and abdominal wall have been associated with morbidity due to the aggressive nature of the surgery and high recurrence rates. Surgery that does not cause functional impairment is desired for patients with desmoid tumors. In the present study, among patients with desmoid tumors who were prospectively and consecutively treated with identical conservative treatment with meloxicam, a selected patients of patients were treated with less invasive surgery than wide-resection. Out of 60 patients pathologically diagnosed with desmoid tumors, 9 patients with tumors refractory to conservative treatment and 4 patients who refused to receive this type of treatment were treated with planned simple resection. Subsequently, the clinical outcome of the patients and the mutational status of the catenin β-1 (CTNNB1) gene in the tumors were analyzed. The mean age of the 13 patients that underwent planned simple resection was 39 years, and the tumors were located in the abdominal wall in 6 cases, the chest wall in 4 cases and the neck in 3 cases. All excised specimens were evaluated and positive microscopic margins were identified; however, during the mean follow-up period of 30 months, 12/13 cases, 7 of which had T41A mutations and 5 of which had no mutations (wild-type), did not develop recurrence. Only 1 initial case with an S45F mutation in the CTNNB1 gene developed recurrence. The results of the present prospectively treated with simple resection and retrospectively analyzed study suggest that planned simple resection could serve as a therapeutic modality for extraperitoneal desmoid tumors, particularly truncal ones with a wild-type or T41A mutational status.
由于手术的侵袭性和高复发率,腹壁外和腹壁的硬纤维瘤与发病率相关。对于硬纤维瘤患者,希望进行不会导致功能障碍的手术。在本研究中,在接受美洛昔康相同保守治疗的硬纤维瘤患者中,部分患者接受了比广泛切除侵入性更小的手术。在60例经病理诊断为硬纤维瘤的患者中,9例对保守治疗难治的肿瘤患者和4例拒绝接受此类治疗的患者接受了计划性单纯切除。随后,分析了患者的临床结局以及肿瘤中连环蛋白β-1(CTNNB1)基因的突变状态。接受计划性单纯切除的13例患者的平均年龄为39岁,肿瘤位于腹壁6例,胸壁4例,颈部3例。对所有切除标本进行了评估,并确定了显微镜下切缘阳性;然而,在平均30个月的随访期内,13例中有12例未复发,其中7例有T41A突变,5例无突变(野生型)。只有1例最初的CTNNB1基因有S45F突变的病例出现了复发。本前瞻性单纯切除治疗并回顾性分析研究的结果表明,计划性单纯切除可作为腹膜外硬纤维瘤的一种治疗方式,特别是对于具有野生型或T41A突变状态的躯干硬纤维瘤。